JH
Jeffrey Hung Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
46
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
89.5%
Neutral
10.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $129 |
17%
upside
| 3 | +24% |
0
%
| 16 Oct ‘25 2 days ago |
|
|
|
Overweight
Maintained
| $77 |
85%
upside
| 1 | -9.5% |
0
%
| 29 Sep ‘25 19 days ago |
|
|
|
Overweight
Maintained
| $167 |
23%
upside
| 4 | +0.39% |
0
%
| 24 Sep ‘25 24 days ago |
|
|
|
Overweight
Maintained
| $79 |
91%
upside
| 1 | +13% |
0
%
| 17 Sep ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $18 |
93%
upside
| 1 | +35% |
0
%
| 12 Sep ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $163 |
16%
upside
| 3 | -0.35% |
0
%
| 5 Sep ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $71 |
8%
upside
| 2 | +9.6% |
0
%
| 20 Aug ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $28 |
256%
upside
| 1 | -3.7% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $21 |
79%
upside
| 1 | +41% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
|
Equal-Weight
Downgraded
| $2 |
17%
downside
| 1 | +15% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
|
Equal-Weight
Maintained
| $13 |
59%
upside
| 1 | – |
–
| 12 Aug ‘25 2 months ago |
|